Insider Monkey
Here’s What Analysts Are Saying About Bristol-Myers Squibb Company (BMY)
📈
AI Sentiment
Highly Positive
8/10
Bristol-Myers Squibb Company News
Latest updates and market news for BMY
16 news
Feb 9 - Feb 15, 2026
Page 1
Simply Wall St.
Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus
📊
AI Sentiment
Positive
7/10
24/7 Wall St.
This Is Graco’s Dividend Score After Paying Investors
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Bristol-Myers Squibb Company (BMY) Growth Portfolio Driving Earnings Growth
📈
AI Sentiment
Highly Positive
9/10
StockStory
The 5 Most Interesting Analyst Questions From Bristol-Myers Squibb’s Q4 Earnings Call
📈
AI Sentiment
Highly Positive
9/10
PR Newswire
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
📈
AI Sentiment
Highly Positive
9/10
Zacks
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
➖
AI Sentiment
Neutral
5/10
ACCESS Newswire
Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Is Bristol Myers Squibb (BMY) Pricing Reflecting Its Recent Share Price Rebound?
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Bristol-Myers Squibb (BMY) Is Up 8.7% After Profit Rebound And Pipeline Outlook - Has The Bull Case Changed?
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Bristol Myers Squibb AI Trials And 2026 Readouts Reframe Valuation
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Assessing Bristol Myers Squibb (BMY) Valuation After Earnings Beat And Pipeline Optimism
📈
AI Sentiment
Highly Positive
8/10
Zacks
BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating
📈
AI Sentiment
Highly Positive
9/10
Business Wire
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence
📈
AI Sentiment
Highly Positive
9/10
Share this news page